10x Genomics: Stuck In Neutral
Source: SeekingAlpha
2025-06-23 13:47:36 ET
Today, I am putting life sciences company 10x Genomics, Inc.. ( TXG ) in the spotlight for the first time. TXG stock is down 45% over the past 12 months but has been moving up over the past couple of months. The company posted better than expected first quarter results in May. 10x Genomics also settle global litigation issues with competitor Bruker ( BRKR ) in mid-May. What's ahead for 10x Genomics? An initial analysis follows below....
Read the full article on Seeking Alpha
For further details see:
10x Genomics: Stuck In Neutral
10x Genomics Inc.
NASDAQ: TXG
TXG Trading
-1.09% G/L:
$19.06 Last:
556,930 Volume:
$18.97 Open:
TXG Latest News
August 27, 2025 04:05:00 pm
10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
TXG Stock Data
$2,439,310,058
122,629,906
0.14%
123
N/A
Biotechnology & Life Sciences
Healthcare
US
Pleasanton
